IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer
- Conditions
- Interventions
- First Posted Date
- 2006-04-21
- Last Posted Date
- 2007-11-01
- Lead Sponsor
- Hokkaido Gastrointestinal Cancer Study Group
- Target Recruit Count
- 200
- Registration Number
- NCT00316745
- Locations
- π―π΅
Hokkaido University Hospital (Hokkaido University Graduate School of Medicine / School of Medicine), Sapporo, Hokkaido, Japan
Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal Cancer
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2006-04-21
- Lead Sponsor
- Hokkaido Gastrointestinal Cancer Study Group
- Target Recruit Count
- 30
- Registration Number
- NCT00209703
- Locations
- π―π΅
Hokkaido University Hospital (Hokkaido University Graduate School of Medicine), Sapporo, Hokkaido, Japan
Phase I/II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2006-04-21
- Lead Sponsor
- Hokkaido Gastrointestinal Cancer Study Group
- Target Recruit Count
- 24
- Registration Number
- NCT00209638
Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2005-09-21
- Lead Sponsor
- Hokkaido Gastrointestinal Cancer Study Group
- Target Recruit Count
- 23
- Registration Number
- NCT00209625
- Locations
- π―π΅
Hokkaido University Hospital, Sapporo, Hokkaido, Japan
Phase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal Cancer
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2007-11-01
- Lead Sponsor
- Hokkaido Gastrointestinal Cancer Study Group
- Target Recruit Count
- 40
- Registration Number
- NCT00209651
- Locations
- π―π΅
Hokkaido University Hospital, Sapporo, Hokkaido, Japan
Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2006-02-02
- Lead Sponsor
- Hokkaido Gastrointestinal Cancer Study Group
- Target Recruit Count
- 40
- Registration Number
- NCT00209664
- Locations
- π―π΅
Hokkaido University Hospital, Sapporo, Hokkaido, Japan
Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC.
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2009-02-17
- Lead Sponsor
- Hokkaido Gastrointestinal Cancer Study Group
- Target Recruit Count
- 40
- Registration Number
- NCT00209612
- Locations
- π―π΅
γ» Hokkaido University Hospital (Hokkaido University Graduate School of Medicine / School of Medicine), Sapporo, Hokkaido, Japan
Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer.
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2010-05-26
- Lead Sponsor
- Hokkaido Gastrointestinal Cancer Study Group
- Target Recruit Count
- 50
- Registration Number
- NCT00209729
- Locations
- π―π΅
Hokkaido University Hospital (Hokkaido University Graduate School of Medicine), Sapporo, Hokkaido, Japan
Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer.
- Conditions
- Interventions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2010-05-26
- Lead Sponsor
- Hokkaido Gastrointestinal Cancer Study Group
- Target Recruit Count
- 30
- Registration Number
- NCT00209716
- Locations
- π―π΅
γ» Hokkaido University Hospital (Hokkaido University Graduate School of Medicine), Sapporo, Hokkaido, Japan
Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2010-05-26
- Lead Sponsor
- Hokkaido Gastrointestinal Cancer Study Group
- Target Recruit Count
- 340
- Registration Number
- NCT00209742
- Locations
- π―π΅
γ» Hokkaido University Hospital (Hokkaido University Graduate School of Medicine / School of Medicine), Sapporo, Hokkaido, Japan